GlaxoSmithKline's market cap is currently £65.53B. The company's EPS TTM is p0.449; its P/E ratio is 19.40; and it has a dividend yield of 3.60%. GlaxoSmithKline is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is p0.47. See an overview of income statement, balance sheet, and cash flow financials.
